Vivimusta is given by a doctor or nurse and billed by the clinic, not a pharmacy. Your care team and your insurance decide which product you get, so ask them what you’d pay.

How do you pay?

How to pay the least

Given by your care team

Billed by the clinic

Vivimusta is given by a doctor or nurse, not picked up at a pharmacy.

  1. Ask your care team or your plan what you’d pay before your visit.

Compare every option

Question
Brand nameVivimusta
Authorized genericbendamustine
Regular genericbendamustine
What you’d pay
Cash priceAsk the pharmacy
Not soldThere isn’t one
Not soldNone found
Same as Vivimusta?
The original
–
–

Brand nameThe maker’s card

Vivimusta CONNECT Co-pay Savings Program

Savings card from Azurity Pharmaceuticals (Slayback Pharma)

No insuranceNeeds insuranceNo cash price listed.
Insurance · as little as $10 a cycle

Sign up on vivimusta.azuritysolutions.com 

Or call 1-844-472-2628.

In the maker’s words

“Pay as little as $10 with an annual maximum…”

From the maker’s offer on vivimusta.azuritysolutions.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Authorized genericNot sold

There isn’t one. An authorized generic is Vivimusta itself, from the same company, sold without the brand name, and usually for less. For now Vivimusta is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

We didn’t find one. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

VIVIMUSTA is an alkylating drug indicated for treatment of patients with: • Chronic lymphocytic leukemia (CLL). Efficacy relative to first line therapies other than chlorambucil has not been established. • Indolent B-cell non-Hodgkin lymphoma (NHL) that has progressed during or within six months of treatment with rituximab or a rituximab-containing regimen.

Source: the FDA label for Vivimusta (Azurity Pharmaceuticals, Inc.), April 3, 2025. Full label on DailyMed 

Good to know